loader image
Sunday, December 21, 2025
72.8 F
McAllen
- Advertisement -

Progress to Understand Presence of Asbestos in Cosmetic Products

Translate to Spanish or other 102 languages!

The FDA will continue its efforts to protect consumers by conducting further testing of talc-containing cosmetics products in order to assess the presence of asbestos. Image for illustration purposes.

Mega Doctor News

- Advertisement -

The following quote is attributed to Linda Katz, director of the FDA’s Office of Cosmetics and Colors:

“The FDA remains dedicated to keeping consumers safe from contaminated cosmetic products. As part of these continued efforts, the FDA’s most recent survey to assess certain talc-containing cosmetic products for the presence of asbestos found that all 50 samples tested negative for detectable asbestos.

Asbestos is a known human carcinogen, and its health risks are well-documented. The FDA will continue its efforts to protect consumers by conducting further testing of talc-containing cosmetics products in order to assess the presence of asbestos. The results of the next survey will be released next year. As it has in the past, the FDA will take prompt action to inform the public and to work closely with companies to help remove any products from the market that are found to contain asbestos.”

- Advertisement -

Additional Information

  • The U.S. Food and Drug Administration today issued the final results from the agency’s year-long sampling assignment to test talc-containing cosmetic products for the presence of asbestos. The full Fiscal Year 2020-2021 results show that all 50 samples assessed were negative for asbestos.
  • Talc is an ingredient used in many cosmetics, from baby powder to blush.
  • In the fall of 2018, the FDA formed the Interagency Working Group on Asbestos in Consumer Products, with members from eight federal agencies to support the development of standardized testing methods for asbestos and other mineral particles of health concern in talc that could potentially affect consumer product safety. On February 4, 2020, the FDA held a public meeting on the preliminary recommendations from this interagency working group on testing methods for asbestos in talc and cosmetic products containing talc.
  • The FDA will conduct another talc sampling assignment in 2022, with 50 additional talc-containing cosmetic product samples selected for blinded testing and will communicate any results that indicate the presence of asbestos, if found. The final results are expected to be released next year.
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 

DHR Health Awarded Large Employer of the Year by Texas Workforce Commission

Workforce Solutions Lower Rio Grande Valley (WFS) proudly announced that its nominee, DHR Health, has been awarded the Large Employer of the Year Award at the 28th Annual Texas Workforce Commission (TWC) Conference.

3D-Printed Models Improve Precision in Cancer Surgery

Using custom 3D-printed models to plan head and neck cancer surgeries increased precision, achieving complete tumor removal in 92% of cases with bone invasion in a recent study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
- Advertisement -
×